Citation Impact
Citing Papers
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A Systematic Review and Meta-analysis of Interventions for Sexual Health Promotion Involving Serious Digital Games
2014 Standout
Invasive Aspergillosis in Hematological Patients
2016
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
2013 StandoutNobel
Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs
2013
Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017
2019
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
2018
Cohort Profile: The International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study
2012
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity
2023 StandoutNobel
Hepatitis C: The next 25 years
2014 StandoutNobel
Applying genomic and transcriptomic advances to mitochondrial medicine
2021
Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C
2015
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Type III Interferons in Hepatitis C Virus Infection
2016
Hallmarks of aging: An expanding universe
2023 Standout
Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
2014
Mixed HCV infection and reinfection in people who inject drugs—impact on therapy
2015
AspergillusPolymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing
2015
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection
2011
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Acceptability and Feasibility of Using Established Geosocial and Sexual Networking Mobile Applications to Promote HIV and STD Testing Among Men Who Have Sex with Men
2014
The past, present and future of neutralizing antibodies for hepatitis C virus
2014
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
2009
A user-centered model for designing consumer mobile health (mHealth) applications (apps)
2016 Standout
Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM
2011
Adaptive Immunity to the Hepatitis C Virus
2010
Hepatitis C reinfection after sustained virological response
2016
Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
2018
Protective Immunity Against Hepatitis C: Many Shades of Gray
2014
Efficacy of text messaging-based interventions for health promotion: A meta-analysis
2013
HCV epidemiology in high-risk groups and the risk of reinfection
2016
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
2016
What Is Killing People with Hepatitis C Virus Infection?
2011
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
2013
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
The global problem of antifungal resistance: prevalence, mechanisms, and management
2017
Challenges and Promise of a Hepatitis C Virus Vaccine
2019
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Mapping mHealth Research: A Decade of Evolution
2013
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
2012
Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets
2016 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs
2019 StandoutNobel
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus
2017 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Anti‐viral therapy for prevention of perinatalHBV transmission: extending therapy beyond birth does not protect against post‐partum flare
2014
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Antimicrobial photodynamic therapy – what we know and what we don’t
2018 Standout
PCR in Diagnosis of Invasive Aspergillosis: a Meta-Analysis of Diagnostic Performance
2014
The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative
2017
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs
2014
Works of Timothy Spelman being referenced
Clinical and virological factors that predict post partum flares in pregnant women with chronic HBV
2013
A randomised controlled trial using mobile advertising to promote safer sex and sun safety to young people
2011
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
2011
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC3Study
2015
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
2013
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status
2016
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users
2008